Portfolio company

Israel

Sector:  Life Sciences

Breaking the boundaries in brain and neurological disease diagnosis the company is finding solutions for direct and real-time diagnosis of Dementia, Alzheimers, Stroke, silent cerebrovascular disease, and cerebral small vessels disease.

It is employing new, cutting-edge technologies with breakthrough scientific and technological R&D.

The company created the first non-invasive probe for direct brain network visualization.

Product:

Dephi MD

The First Objective, Patient-Independent System for Visualization of Brain Health. Delphi·MD offers physicians an ‘in office’ brain physiology and health scan that does not require patient participation or relay on cognitive testing. The Delphi Magnetic probe directly ‘pings’ specific brain networks producing an ‘ECG’ like signature of brain electrophysiological response that is robustly similar in healthy brain networks but changes significantly in pathological states.